Hypolipidemic treatment after myocardial infarction

Morand, P.; Roquebrune, J.P.; Fredenrich, A.; Morand, P; Roquebrune, J.P; Fredenrich, A

Home

>

Node

>

Subnode

Hypolipidemic treatment after myocardial infarction

Morand, P.; Roquebrune, J.P.; Fredenrich, A.

Archives des Maladies du Coeur et des Vaisseaux 85(Special Issue 2): 151-156

1992

ISSN/ISBN: 0003-9683

PMID: 1285696

Document Number: 398582

Treatment of hyperlipidaemia is even more important after than before myocardial infarction. Currently available data should be confirmed by larger studies including women and lasting over 10 years. Analysis of the results would be facilitated by studying comparable groups with respect to left ventricular function and severity of the coronary disease. The total serum cholesterol should optimally be under 2 g/l and the LDL-cholesterol under 1.30 g/l. However, coronary artery disease is a multifactorial condition and the correction of only one predisposing factor, albeit a major one, is not sufficient for effective prevention.